MediWound Ltd. (MDWD)
- Previous Close
17.66 - Open
17.83 - Bid 18.13 x 200
- Ask 18.27 x 100
- Day's Range
17.65 - 18.49 - 52 Week Range
7.10 - 18.75 - Volume
73,007 - Avg. Volume
73,792 - Market Cap (intraday)
173.129M - Beta (5Y Monthly) 0.93
- PE Ratio (TTM)
-- - EPS (TTM)
-0.75 - Earnings Date May 28, 2024 - Jun 3, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
28.50
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
www.mediwound.comRecent News: MDWD
Performance Overview: MDWD
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MDWD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MDWD
Valuation Measures
Market Cap
173.13M
Enterprise Value
137.94M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.80
Price/Book (mrq)
5.48
Enterprise Value/Revenue
7.38
Enterprise Value/EBITDA
-28.73
Financial Highlights
Profitability and Income Statement
Profit Margin
-35.94%
Return on Assets (ttm)
-16.64%
Return on Equity (ttm)
-31.60%
Revenue (ttm)
18.69M
Net Income Avi to Common (ttm)
-6.72M
Diluted EPS (ttm)
-0.75
Balance Sheet and Cash Flow
Total Cash (mrq)
41.54M
Total Debt/Equity (mrq)
20.52%
Levered Free Cash Flow (ttm)
-10.12M